T-cell rich B-cell lymphoma

Summary about Disease


T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a rare subtype of diffuse large B-cell lymphoma (DLBCL). It's characterized by a relatively small number of large B cells (the malignant cells) surrounded by a large number of T cells and histiocytes (immune cells). THRLBCL is an aggressive lymphoma, but treatment can be effective.

Symptoms


Common symptoms include:

Swollen lymph nodes (usually painless) in the neck, armpit, or groin

Fever

Night sweats

Unexplained weight loss

Fatigue

Enlarged spleen (splenomegaly)

Enlarged liver (hepatomegaly)

Causes


The exact cause of THRLBCL is unknown. Like other lymphomas, it's thought to arise from a combination of genetic mutations and environmental factors. It is not usually considered hereditary.

Medicine Used


The standard treatment for THRLBCL is chemotherapy, often involving a combination of drugs. Common medications include:

R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)

Other chemotherapy regimens may be used depending on the individual case.

In some cases, stem cell transplantation (bone marrow transplant) may be considered.

Is Communicable


No, THRLBCL is not communicable. It is not an infectious disease and cannot be spread from person to person.

Precautions


Since THRLBCL is not communicable, there are no precautions to take to prevent its spread. General healthy lifestyle choices like eating a balanced diet, regular exercise, and avoiding smoking could help lower the risk of certain cancers, but there is no proven prevention strategy specifically for THRLBCL. Patients undergoing treatment for THRLBCL may need to take precautions related to their weakened immune system (e.g., avoiding crowds, practicing good hygiene).

How long does an outbreak last?


THRLBCL is not an outbreak. Lymphoma is a cancer. The disease duration without treatment is variable and depends on the individual case. Treatment aims to achieve remission, and if successful, the lymphoma may not return. However, relapse is possible.

How is it diagnosed?


Diagnosis typically involves:

Physical Exam: Checking for swollen lymph nodes and other signs of the disease.

Lymph Node Biopsy: Removing a lymph node and examining it under a microscope. This is crucial for confirming the diagnosis and identifying the specific type of lymphoma.

Bone Marrow Biopsy: Taking a sample of bone marrow to see if the lymphoma has spread there.

Imaging Tests: CT scans, PET scans, and MRI scans to assess the extent of the lymphoma in the body.

Blood Tests: Complete blood count, liver and kidney function tests, and other blood tests to evaluate overall health and organ function.

Immunohistochemistry and Flow Cytometry: These tests are performed on the biopsy sample to identify specific markers on the lymphoma cells, helping to classify the lymphoma.

Timeline of Symptoms


The onset and progression of symptoms can vary. Some people may experience a rapid onset of symptoms, while others may have a more gradual development. The timeline can be different for each person.

Important Considerations


THRLBCL is a rare and aggressive lymphoma. Early diagnosis and treatment are important.

Treatment options and prognosis depend on the stage of the lymphoma, the patient's overall health, and other factors.

Patients should discuss their treatment options and potential side effects with their healthcare team.

Clinical trials may be an option for some patients.

Follow-up care is important to monitor for relapse.